Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-Analysis

Objective. Mesenchymal stem cell (MSC) therapy has been explored in Huntington disease (HD) as a potential therapeutic approach; however, a complete synthesis of these results is lacking. We conducted a meta-analysis to evaluate the effects of MSCs on HD. Method. Eligible studies published before No...

Full description

Saved in:
Bibliographic Details
Main Authors: Xue-Song Liang, Zheng-Wu Sun, Aline M. Thomas, Shen Li
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2023/1109967
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850177703153500160
author Xue-Song Liang
Zheng-Wu Sun
Aline M. Thomas
Shen Li
author_facet Xue-Song Liang
Zheng-Wu Sun
Aline M. Thomas
Shen Li
author_sort Xue-Song Liang
collection DOAJ
description Objective. Mesenchymal stem cell (MSC) therapy has been explored in Huntington disease (HD) as a potential therapeutic approach; however, a complete synthesis of these results is lacking. We conducted a meta-analysis to evaluate the effects of MSCs on HD. Method. Eligible studies published before November 2022 were screened from Embase, PubMed, Web of Science, Medline, and Cochrane in accordance with PRISMA guidelines. ClinicalTrial.gov and the World Health Organization International Clinical Trials Registry Platform were also searched for registered clinical trials. The outcomes in rodent studies evaluated included morphological changes (striatal volume and ventricular volume), motor function (rotarod test, wire hang test, grip strength test, limb-clasping test, apomorphine-induced rotation test, and neuromuscular electromyography activity), cognition (Morris water maze test), and body weight. Result. The initial search returned 362 records, of which 15 studies incorporating 346 HD rodents were eligible for meta-analysis. Larger striatal and smaller ventricular volumes were observed in MSC-treated animals compared to controls. MSCs transplanted before the occurrence of motor dysfunction rescued the motor incoordination of HD. Among different MSC sources, bone marrow mesenchymal stem cells were the most investigated cells and were effective in improving motor coordination. MSC therapy improved muscle strength, neuromuscular electromyography activity, cortex-related motor function, and striatum-related motor function, while cognition was not changed. The body weight of male HD rodents increased after MSC transplantation, while that of females was not affected. Conclusion. Meta-analysis showed a positive effect of MSCs on HD rodents overall, as reflected in morphological changes, motor coordination, muscle strength, neuromuscular electromyography activity, cortex-related motor function, and striatum-related motor function, while cognition was not changed by MSC therapy.
format Article
id doaj-art-c42916c46b4f4e2696f16ed4587ba87a
institution OA Journals
issn 1687-9678
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-c42916c46b4f4e2696f16ed4587ba87a2025-08-20T02:18:55ZengWileyStem Cells International1687-96782023-01-01202310.1155/2023/1109967Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-AnalysisXue-Song Liang0Zheng-Wu Sun1Aline M. Thomas2Shen Li3Department of Neurology and PsychiatryDepartment of Clinical PharmacyThe Russell H. Morgan Department of Radiology and Radiological SciencesDepartment of Neurology and PsychiatryObjective. Mesenchymal stem cell (MSC) therapy has been explored in Huntington disease (HD) as a potential therapeutic approach; however, a complete synthesis of these results is lacking. We conducted a meta-analysis to evaluate the effects of MSCs on HD. Method. Eligible studies published before November 2022 were screened from Embase, PubMed, Web of Science, Medline, and Cochrane in accordance with PRISMA guidelines. ClinicalTrial.gov and the World Health Organization International Clinical Trials Registry Platform were also searched for registered clinical trials. The outcomes in rodent studies evaluated included morphological changes (striatal volume and ventricular volume), motor function (rotarod test, wire hang test, grip strength test, limb-clasping test, apomorphine-induced rotation test, and neuromuscular electromyography activity), cognition (Morris water maze test), and body weight. Result. The initial search returned 362 records, of which 15 studies incorporating 346 HD rodents were eligible for meta-analysis. Larger striatal and smaller ventricular volumes were observed in MSC-treated animals compared to controls. MSCs transplanted before the occurrence of motor dysfunction rescued the motor incoordination of HD. Among different MSC sources, bone marrow mesenchymal stem cells were the most investigated cells and were effective in improving motor coordination. MSC therapy improved muscle strength, neuromuscular electromyography activity, cortex-related motor function, and striatum-related motor function, while cognition was not changed. The body weight of male HD rodents increased after MSC transplantation, while that of females was not affected. Conclusion. Meta-analysis showed a positive effect of MSCs on HD rodents overall, as reflected in morphological changes, motor coordination, muscle strength, neuromuscular electromyography activity, cortex-related motor function, and striatum-related motor function, while cognition was not changed by MSC therapy.http://dx.doi.org/10.1155/2023/1109967
spellingShingle Xue-Song Liang
Zheng-Wu Sun
Aline M. Thomas
Shen Li
Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-Analysis
Stem Cells International
title Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-Analysis
title_full Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-Analysis
title_fullStr Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-Analysis
title_full_unstemmed Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-Analysis
title_short Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-Analysis
title_sort mesenchymal stem cell therapy for huntington disease a meta analysis
url http://dx.doi.org/10.1155/2023/1109967
work_keys_str_mv AT xuesongliang mesenchymalstemcelltherapyforhuntingtondiseaseametaanalysis
AT zhengwusun mesenchymalstemcelltherapyforhuntingtondiseaseametaanalysis
AT alinemthomas mesenchymalstemcelltherapyforhuntingtondiseaseametaanalysis
AT shenli mesenchymalstemcelltherapyforhuntingtondiseaseametaanalysis